Safety study of HEC-007 injection in healthy and overweight people
This trial tests a new injection, HEC-007, to see if it is safe in healthy adults and in people who are overweight or obese. It may help with weight management and related health issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy adult aged 18 to 65, or you are overweight or obese with a BMI of 24 or higher.
- If you are overweight (BMI 24 to 28), you also have at least one condition like prediabetes, high blood pressure, or fatty liver.
- You have not been diagnosed with type 1 or type 2 diabetes.
- You agree to use effective birth control for 6 months after the last dose, if you or your partner could become pregnant.
- You have not used any GLP-1 medicines (like Ozempic) in the last 6 months.
- You have no history of thyroid cancer or pancreatitis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injected medicine (called HS-20136-2) to see if it is safe and how the body handles it. It is an early (phase 1) trial that includes healthy people and people with overweight, and the goal is to learn about possible effects on weight and metabolism.
This early-phase trial tests the safety and tolerability of a new injection called HRS-5817 in healthy volunteers. It helps researchers understand how the drug moves through the body and what side effects it might have.
This study tests the safety of a new oral medication called HRS-1597 in two groups: healthy people with normal weight and people who are overweight or obese. It will help determine if the drug is safe and how the body processes it.
This study tests an experimental injection called HDM1005 for adults with obesity who do not have diabetes. The goal is to see if it helps with weight loss when combined with diet and exercise.
This study tests a new injection called HEC-151 in healthy men to see how it affects the body at different single doses. It's one of the first steps to see if the drug is safe and could one day help people with diabetes or related conditions.
This study tests a new injected medicine called SYH2092 in healthy adults. It aims to see how safe it is and how the body handles it, which could help develop a future treatment for conditions like diabetes or obesity.
Hear when a new Healthy Subjects trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.